Pain Res Manage 2007 Pharmacological management of chronic

  • Slides: 24
Download presentation

Pain Res Manage 2007 Pharmacological management of chronic neuropathic pain – Consensus statement and

Pain Res Manage 2007 Pharmacological management of chronic neuropathic pain – Consensus statement and guidelines from the Canadian Pain Society

ΑΝΑΛΓΗΤΙΚΑ ΤΡΙΤΗΣ ΓΡΑΜΜΗΣ THIRD -LINE ANALGESICS �Tramadol for the mu opioid receptor, and inhibits

ΑΝΑΛΓΗΤΙΚΑ ΤΡΙΤΗΣ ΓΡΑΜΜΗΣ THIRD -LINE ANALGESICS �Tramadol for the mu opioid receptor, and inhibits reuptake of noradrenaline and serotonin ή �Opioid analgesics Canadian Pain Society

The Neuropathic Pain Special Interest Group of the International Association for the Study of

The Neuropathic Pain Special Interest Group of the International Association for the Study of of evidence-based guidelines for the pharmacological treatment of neuropathic pain, 2010 �Tricyclic antidepressants, � SNRI dual reuptake inhibitors of serotonin and norepinephrine, Gabapentin και Pregabalin �Topical lidocaine were recommended � �as First-Line treatment options on the basis of the results of randomized clinical trials (RCTs). � 2010 Mayo Clinic

The Neuropathic Pain Special Interest Group of the International Association for the Study of

The Neuropathic Pain Special Interest Group of the International Association for the Study of of evidence-based guidelines for the pharmacological treatment of neuropathic pain �Opioid analgesics and tramadol �as second-line treatments 2010 Mayo Clinic